36 results
DRS/A
EX-10.7
YMAB
Y-Mabs Therapeutics Inc
8 Jun 18
Draft registration statement (amended)
12:00am
, business unit, or individual goals (including, but not limited to, continued employment or service), or any other basis determined by the Administrator … , and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at one hundred
8-K
EX-99.1
YMAB
Y-Mabs Therapeutics Inc
14 Mar 24
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
9:17am
the future of the Company’s business, including with respect to expansion and its goals; the Company’s plans and strategies, development
8-K
EX-99.1
YMAB
Y-Mabs Therapeutics Inc
1 Jul 19
Y-mAbs Announces Recruitment Status for Pivotal Trials
9:02am
an important milestone by reaching our initial patient recruitment goals for both compounds and focus on advancing these treatments to give children access
8-K
EX-99.1
z1kr27
4 Mar 24
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
6:05am
DRS/A
EX-10.9
t0xfu53 5qi50
8 Jun 18
Draft registration statement (amended)
12:00am
8-K
EX-99.1
ljbe 7qe4lodymfyto
7 May 24
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
4:10pm
8-K
EX-99.1
i15pjt
10 Aug 23
Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
4:30pm
8-K
EX-99.1
46f03pjqrsje3ucni
29 Feb 24
Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
4:04pm
8-K
EX-99.1
g57 54ia7rpsw
13 Nov 23
Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
4:47pm
8-K
4o8eum8kkhyb2hvfk
18 Oct 23
Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director
4:09pm
8-K
EX-99.1
8h7xd ivk
9 Jan 24
Results of Operations and Financial Condition
6:45am